Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant

BACKGROUND: Weight loss is often difficult to achieve in individuals with type 2 diabetes and anti-obesity drugs are often advocated to support dietary intervention. Despite the extensive use of centrally acting anti-obesity drugs, there is little evidence of how they affect dietary composition. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Heppenstall, Charlotte, Bunce, Susan, Smith, Jamie C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479018/
https://www.ncbi.nlm.nih.gov/pubmed/22824101
http://dx.doi.org/10.1186/1475-2891-11-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479018/
https://www.ncbi.nlm.nih.gov/pubmed/22824101
http://dx.doi.org/10.1186/1475-2891-11-50

Ejemplares similares